𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Dose-dependent pharmacokinetics of SP-8203 in rats

✍ Scribed by Joo H. Lee; Young H. Choi; Jung H. Suh; Hee E. Kang; Tae H. Lee; Il H. Cho; Myung G. Lee


Publisher
John Wiley and Sons
Year
2010
Tongue
English
Weight
88 KB
Volume
31
Category
Article
ISSN
0142-2782

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


DOSE DEPENDENT PHARMACOKINETICS OF NAPRO
✍ Sarfaraz K. Niazi; S. Mahmood Alam; S. I. Ahmad πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 389 KB πŸ‘ 2 views

The pharmacokinetics of one of the most widely used non-steroidal antiinflammatory drugs, naproxen, were studied in 28 healthy human volunteers at the two most commonly used dose levels, viz., 250 mg and 500 mg, in a cross-over design. The plasma levels of naproxen were analysed by a modified high-p

Dose-dependent pharmacokinetics of a new
✍ Young Hoon Kim; Sun Dong Yoo; You Sun Kim; Kyung Hee Lee; Hye Suk Lee πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 126 KB πŸ‘ 2 views

## Abstract The dose‐dependency of the pharmacokinetics of a new Na^+^/H^+^ exchanger inhibitor, KR‐33028 was evaluated in rats after intravenous and oral administration. After intravenous administration of KR‐33028 (1, 5, 10 and 20mg/kg doses), the systemic clearance (__Cl__) was reduced and __AUC

Dose-dependent pharmacokinetics and firs
✍ Young H. Choi; Young S. Lee; Soo H. Bae; Tae K. Kim; Bong-Y. Lee; Myung G. Lee πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 162 KB πŸ‘ 2 views

## Abstract The pharmacokinetics of mirodenafil and its two metabolites, SK3541 and SK3544, after intravenous (5, 10, 20 and 50 mg/kg) and oral (10, 20 and 50 mg/kg) administration of mirodenafil, and the first‐pass effect of mirodenafil after intravenous, oral, intraportal, intragastric and intrad

Dose-dependent pharmacokinetics of a new
✍ Hee J. Kim; So H. Kim; Sun-O. Kim; Dong-H. Lee; Hong Lim; Sung-E. Yoo; Myung G. πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 108 KB πŸ‘ 2 views

## Abstract The dose‐dependent pharmacokinetic parameters of a new neuroprotective agent for ischemia‐reperfusion damage, KR‐31378, were evaluated after intravenous and oral administration, 10, 20, and 50 mg/kg, to rats. After intravenous administration of 50 mg/kg, the dose‐normalized (10 mg/kg) A